EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis ...

Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...

Aggressive treatment for patients who look like they may soon develop rheumatoid arthritis (RA) appears very effective for ...

A population-based cross-sectional study published in Clinical Rheumatology reveals that individuals with rheumatoid ...

A recent study discovered an exponential rise in rheumatoid arthritis all across the globe.Researchers found that the ...

Among patients with mNSCLC receiving ICIs, overall survival was similar between those with vs without coexisting RA.

The Arthritis Foundation is funding a study to help predict the onset and progression of interstitial lung disease in ...

Sleep disturbances have been identified to significantly compromise pain interference in early rheumatoid arthritis (RA) ...

Scipher Medicine, the company behind the groundbreaking PrismRA® test, unveiled a new, AI-driven approach to help doctors better evaluate if a rheumatoid arthritis (RA) treatment is truly working — a ...

Herpes zoster (HZ) is common in older people, with a lifetime risk of 25%. The main risk factors are advanced age and ...

I am writing to express my deep concern regarding the recent announcement that the CHI Arthritis and Rheumatology will be closing its doors. As a member of the community who has benefitted greatly ...